Galderma announces the launch of FACE by Galderma™ – a game-changing augmented reality solution helping healthcare professionals grow their activity and improve patient satisfaction Press release
Galderma expands footprint with new Global Capability Center in Barcelona to support global growth Press release
IMCAS 2023: Galderma to share latest data demonstrating high aesthetic improvement and patient satisfaction across its innovative portfolio Press release
Galderma announces intention to expand manufacturing and innovation footprint in Asia-Pacific Press release
Galderma debuts the Sensitive Skincare Faculty, a global expert group to improve understanding and management of sensitive skin Press release
Galderma showcases its continued commitment to innovation in dermatology with new data to be presented at 2022 EADV congress Press release
Galderma delivers strong H1 2022 results and continued innovation across its leading dermatology portfolio Press release
Galderma announces positive data from phase III trial, demonstrating efficacy and safety of nemolizumab in patients with prurigo nodularis Press release
Galderma announces positive results in two phase III studies for a novel liquid formulation botulinumtoxinA (RelabotulinumtoxinA) for the treatment of glabellar lines (frown) and lateral canthal lines (crow’s feet) Press release
Galderma to present extensive new clinical data across its portfolio of neuromodulators, fillers and biostimulators at the IMCAS World Congress 2022 Press release
